Vivo Capital, LLC Top Holdings and 13F Report (2026) About Vivo Capital, LLCInvestment ActivityVivo Capital, LLC has $1.10 billion in total holdings as of June 30, 2026.Vivo Capital, LLC owns shares of 47 different stocks, but just 21 companies or ETFs make up 80% of its holdings.Approximately 14.22% of the portfolio was purchased this quarter.About 32.31% of the portfolio was sold this quarter.This quarter, Vivo Capital, LLC has purchased 46 new stocks and bought additional shares in 6 stocks.Vivo Capital, LLC sold shares of 8 stocks and completely divested from 6 stocks this quarter.Largest Holdings Trevi Therapeutics $95,015,558Praxis Precision Medicines $90,766,926Erasca $75,614,188Arrivent BioPharma Inc $58,436,050Abivax SA - ADR $55,289,441 Largest New Holdings this Quarter 004468500 - Achieve Life Sciences $17,964,239 Holding28106W103 - Editas Medicine $11,519,010 Holding67613T104 - Odyssey Therapeutics Inc $10,758,250 Holding05153U107 - Aura Biosciences $8,283,336 Holding05338F306 - Avalo Therapeutics Inc $5,082,000 Holding Largest Purchases this Quarter Tenax Therapeutics Inc 2,291,667 shares (about $33.34M)Arrivent BioPharma Inc 796,181 shares (about $27.66M)Abivax SA - ADR 175,360 shares (about $23.37M)Achieve Life Sciences 2,751,032 shares (about $17.96M)Editas Medicine 3,555,250 shares (about $11.52M) Largest Sales this Quarter Erasca 8,024,068 shares (about $147.00M)Tango Therapeutics 775,011 shares (about $24.23M)Praxis Precision Medicines 67,779 shares (about $22.69M)SAB Biotherapeutics Inc 4,120,091 shares (about $16.07M)DBV Technologies SA 822,811 shares (about $13.49M) Sector Allocation Over TimeMap of 500 Largest Holdings ofVivo Capital, LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorTRVITrevi Therapeutics$95,015,5580.0%5,094,6688.7%HealthcarePraxis Precision Medicines$90,766,926$22,691,732 â–¼-20.0%271,1168.3%CommonERASErasca$75,614,188$147,000,926 â–¼-66.0%4,127,4126.9%HealthcareArrivent BioPharma Inc$58,436,050$27,659,328 â–²89.9%1,682,0975.3%CommonAbivax SA - ADR$55,289,441$23,368,474 â–²73.2%414,8995.0%SPONSORED ADSTNGXTango Therapeutics$43,131,579$24,226,844 â–¼-36.0%1,379,7693.9%HealthcareCRVSCorvus Pharmaceuticals$41,918,8910.0%2,805,8163.8%HealthcareBright Minds Biosciences Inc$39,113,4740.0%557,1723.6%CommonSVASinovac Biotech$38,192,4100.0%5,903,0003.5%HealthcareTenax Therapeutics Inc$36,375,000$33,343,755 â–²1,100.0%2,500,0003.3%CommonACRSAclaris Therapeutics$35,414,630$147,967 â–²0.4%6,694,6373.2%HealthcareDyne Therapeutics Inc$34,591,3200.0%1,557,4663.2%CommonDianthus Therapeutics Inc$34,507,7250.0%353,9983.2%CommonAlto Neuroscience Inc$31,901,763$4,573,572 â–²16.7%1,208,8582.9%CommonDBV Technologies SA$30,254,031$13,494,100 â–¼-30.8%1,844,7582.8%SPONSORED ADSSAB Biotherapeutics Inc$28,469,645$16,068,355 â–¼-36.1%7,299,9092.6%CommonMLTXMoonLake Immunotherapeutics$27,258,000$7,788,000 â–²40.0%1,400,0002.5%HealthcareLB Pharmaceuticals Inc$25,964,0000.0%800,0002.4%CommonNERVMinerva Neurosciences$23,991,2460.0%4,322,7472.2%HealthcareDSGNDesign Therapeutics$23,338,7060.0%1,612,9032.1%HealthcareORICOric Pharmaceuticals$20,022,3520.0%1,848,7861.8%HealthcareCAMP4 Therapeutics Corporation$18,557,5020.0%4,246,5681.7%CommonFaeth Therapeutics Inc$18,050,5000.0%722,0201.6%CommonACHVAchieve Life Sciences$17,964,239$17,964,239 â–²New Holding2,751,0321.6%HealthcareCMPXCompass Therapeutics$16,987,961$3,916,609 â–¼-18.7%7,757,0601.6%HealthcareAN2 Therapeutics Inc$15,263,6180.0%3,153,6401.4%CommonEDITEditas Medicine$11,519,010$11,519,010 â–²New Holding3,555,2501.1%HealthcareGERNGeron$11,099,9000.0%8,671,7971.0%HealthcareOdyssey Therapeutics Inc$10,758,250$10,758,250 â–²New Holding575,0001.0%CommonEupraxia Pharmaceuticals Inc$8,923,5000.0%1,350,0000.8%CommonOnkure Therapeutics Inc$8,790,3580.0%1,927,7100.8%CommonOLMAOlema Pharmaceuticals$8,404,7560.0%671,8430.8%HealthcareMonopar Therapeutics Inc$8,379,3950.0%90,5000.8%CommonAURAAura Biosciences$8,283,336$8,283,336 â–²New Holding1,166,6670.8%HealthcareSurrozen Inc$6,747,0000.0%260,0000.6%CommonALXOALX Oncology$6,592,3560.0%3,184,7130.6%HealthcareSatellos Bioscience Inc$6,326,2530.0%813,6660.6%CommonAvalo Therapeutics Inc$5,082,000$5,082,000 â–²New Holding275,0000.5%CommonPEPGPepGen$4,185,0000.0%2,325,0000.4%HealthcareVALNValneva$3,991,531$3,991,531 â–²New Holding763,1990.4%HealthcareSERASera Prognostics$3,003,8010.0%1,650,4400.3%HealthcareUnicycive Therapeutics$2,579,500$5,815,206 â–¼-69.3%550,0000.2%CommonInstil Bio Inc$2,251,1940.0%292,7430.2%CommonInMed Pharmaceuticals Inc$1,237,484$1,237,484 â–²New Holding798,3770.1%CommonBolt Biotherapeutics Inc$278,7940.0%72,4140.0%CommonPasithea Therapeutics Corp$239,904$842,437 â–¼-77.8%465,4710.0%CommonPrecision Biosciences Inc$36,7460.0%4,6750.0%CommonTERNTerns Pharmaceuticals$0$70,350,517 â–¼-100.0%00.0%HealthcareVeradermics Inc$0$18,945,000 â–¼-100.0%00.0%CommonCOGTCogent Biosciences$0$16,254,327 â–¼-100.0%00.0%HealthcareSLNOSoleno Therapeutics$0$9,873,553 â–¼-100.0%00.0%HealthcareVRDNViridian Therapeutics$0$3,252,593 â–¼-100.0%00.0%HealthcareCMPSCompass Pathways$0$1,106,000 â–¼-100.0%00.0%HealthcareShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
